This New Treatment Could be a Game-Changer for Black Men

According to the American Cancer Society, about 1 in 10 men will be diagnosed with prostate cancer in their lifetime. Of those who are diagnosed, six in 10 will be over the age of 65. The condition is also more likely to affect Black Americans more than any other ethnicity. While prostate cancer isn’t an automatic death sentence, it can be tricky to diagnose in the early stages because the symptoms can be so mild. This can lead to many men being diagnosed when the illness is already in its later stages. With this new treatment in play, however, men with more aggressive forms of prostate cancer may have a more positive outlook.  The New Treatment for Prostate Cancer This new treatment is a targeted molecular therapy that uses a combination of theranostic medication to attack a specific molecule. This radiation therapy seeks out the prostate-specific membrane antigen (PSMA) molecule that prostate cancer cells make. The PSMA molecule is usually on the surface of the cancer cells so it can be easily reached by radiation therapy. The treatment would then kill the cancer cells – effectively ridding the body of them.  Doctors are interested in using this theranostic radiation therapy...